date:Mar 11, 2013
ten years time the UK is at the forefront of the global race when it comes to commercialising new technologies.
Synthace's CEO, Sean Ward, commented: This funding will enable us to bring together a unique suite of technologies for the rapid engineering of a micro-organism which can produce a commercially high-value chemical. The project will demonstrate a new way of engineering biology, with timescales in months rather than years, which will impact sectors across the UK and global economies.